Consistent with these mouse genetic studies, the TET1 promoter was shown to be hypermethylated and TET1 expression was repressed in human patients with non-Hodgkin B cell lymphoma (136). The gene discussed is TET1; the disease is B-cell non-Hodgkin lymphoma.